Authors:
SNIJDERS F
DEBOER JB
STEENBERGEN B
SCHOUTEN M
DANNER SA
VANDAM FSAM
Citation: F. Snijders et al., IMPACT OF DIARRHEA AND FECAL INCONTINENCE ON THE DAILY-LIFE OF HIV-INFECTED PATIENTS, AIDS care, 10(5), 1998, pp. 629-637
Citation: Jb. Deboer et al., THE IMPACT OF RELAPSES ON THE HEALTH-RELATED QUALITY-OF-LIFE OF PATIENTS WITH RELAPSE-REMITTING MULTIPLE-SCLEROSIS, Quality of life research, 6(7-8), 1997, pp. 76-76
Authors:
UNAL G
DEMAN RA
BROUWER JT
ESSINKBOT ML
DEBOER JB
BORSBOOM GJJM
Citation: G. Unal et al., A COMPARISON OF QUALITY-OF-LIFE AS MEASURED BY THE EUROQOL WITH HEPATOLOGISTS OPINION ON LIVER-DISEASE STAGE AND ACTIVITY, Quality of life research, 6(7-8), 1997, pp. 396-396
Authors:
UNAL G
DEMAN RA
BROUWER JT
ESSINKBOT ML
DEBOER JB
BORSBOOM GJJM
Citation: G. Unal et al., A COMPARISON OF QUALITY-OF-LIFE AS MEASURED BY THE EUROQOL WITH HEPATOLOGISTS OPINION ON LIVER-DISEASE STAGE AND ACTIVITY, Gut, 41, 1997, pp. 230-231
Authors:
DEBOER JB
SPRANGERS MAG
AARONSON NK
LANGE JMA
VANDAM FSAM
Citation: Jb. Deboer et al., A STUDY OF THE RELIABILITY, VALIDITY AND RESPONSIVENESS OF THE HIV OVERVIEW OF PROBLEMS EVALUATION SYSTEM (HOPES) IN ASSESSING THE QUALITY-OF-LIFE OF PATIENTS WITH AIDS AND SYMPTOMATIC HIV-INFECTION, Quality of life research, 5(3), 1996, pp. 339-347
Citation: Jb. Deboer et al., HEALTH-RELATED QUALITY-OF-LIFE EVALUATION IN HIV-INFECTED PATIENTS - A REVIEW OF THE LITERATURE, PharmacoEconomics, 8(4), 1995, pp. 291-304
Authors:
DEBOER JB
SPRANGERS MAG
AARONSON NK
LANGE JMA
VANDAM FSAM
Citation: Jb. Deboer et al., THE FEASIBILITY, RELIABILITY AND VALIDITY OF THE EORTC QLQ-C30 IN ASSESSING THE QUALITY-OF-LIFE OF PATIENTS WITH A SYMPTOMATIC HIV-INFECTION OR AIDS (CDC-IV), Psychology & health, 9(1-2), 1994, pp. 65-77
Authors:
FRISSEN PHJ
VANDERENDE ME
TENNAPEL CHH
WEIGEL HM
SCHREIJ GS
KAUFFMANN RH
KOOPMANS PP
HOEPELMAN AIM
DEBOER JB
WEVERLING GJ
HAVERKAMP G
DOWD P
MIEDEMA F
SCHUURMAN R
BOUCHER CAB
LANGE JMA
Citation: Phj. Frissen et al., ZIDOVUDINE AND INTERFERON-ALPHA, COMBINATION THERAPY VERSUS ZIDOVUDINE MONOTHERAPY IN SUBJECTS WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The Journal of infectious diseases, 169(6), 1994, pp. 1351-1355
Citation: Jb. Deboer et al., LONGITUDINAL-STUDY ON THE QUALITY-OF-LIFE OF SYMPTOMATIC HIV-INFECTEDPATIENTS IN A TRIAL OF ZIDOVUDINE VERSUS ZIDOVUDINE AND INTERFERON-ALPHA, AIDS, 7(7), 1993, pp. 947-953